openPR Logo
Press release

Depression Screening/Mental Health Market Top Key Player - AstraZeneca, Bristol-Myers Squibb Company, Alkermes, Eli Lilly and Company

12-05-2017 11:59 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Depression Screening/Mental Health Market

Depression Screening/Mental Health Market

Depression and mental health are the significant medical problems over the globe. Expanding pervasiveness of different mental issue, social and ecological changes, and changing way of life are real drivers for the market development. Rising financing for R&D and clinical trials are additionally driving the development for Depression Screening/Mental Health Market. Expanding attention to disarranges and medicines, quick selection of new treatments and medications, and mechanical progression are key drivers for the market. The Global Depression Screening/Mental Health market is growing at the CAGR of ~4.5% during the forecast period and expected to reach US$ 11245.6 million by 2023.

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/3806 .

Competitive Landscapes:

Some of the key players in this market are: Alkermes (Republic of Ireland), ALLERGAN (Republic of Ireland), AstraZeneca (UK), Bristol-Myers Squibb Company (US), Eli Lilly and Company (US), F. Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson Services, Inc. (US), Novartis AG (Switzerland), Otsuka Holdings Co.,Ltd. (Japan), Pfizer Inc. (US), and others.

Regional analysis of global depression screening/mental health market:

Considering the worldwide situation of the market, the Americas hold the biggest piece of the pie because of different factors, for example, accessibility progressed analytic and treatment, financing for inquire about, expanding number of patients with psychological sickness and related issue. Expanding stress and changing way of life is driving the development for European Depression Screening/Mental Health Industry. It is the second biggest where the west European nations are commanding the biggest piece of the overall industry. Expanding predominance of mental issue, quickly changing medicinal services part, and expanding human services spending are significant development drivers for Asia Pacific Depression Screening/Mental Health market. Center East and Africa (ME&A) is probably going to have a restricted development in the market because of some central point like low information of disarranges and medications, low-salary, and constrained access to social insurance offices.

Brief TOC

Report Prologue
Introduction
Research Methodology
Market Dynamics
Market Factor Analysis
Global Depression Screening/Mental Health Market By Diagnosis
Global Depression Screening/Mental Health Market By Diagnosis
Global Depression Screening/Mental Health Market By Treatment
Global Depression Screening/Mental Health Market By End User
Global Depression Screening/Mental Health Market By Region
Competitive Landscape
Company Profile
Conclusion
Appendix

Ask to Expert @ https://www.marketresearchfuture.com/enquiry/3806 .

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Akash Anand,
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Depression Screening/Mental Health Market Top Key Player - AstraZeneca, Bristol-Myers Squibb Company, Alkermes, Eli Lilly and Company here

News-ID: 845550 • Views:

More Releases from Market Research Future

Generative AI in Fintech Market to Grow at a CAGR of 24.5% by 2032
Generative AI in Fintech Market to Grow at a CAGR of 24.5% by 2032
Generative AI in Fintech Market Overview: Generative AI has been making significant strides in the FinTech market, offering a wide range of applications and opportunities for growth. Market Size and Growth: The generative AI in fintech Market is projected to grow from USD 1,111.0 million in 2023 to USD 7,984.6 million by 2032, exhibiting a compound annual growth rate (CAGR) of 24.5% during the forecast period (2023 - 2032). Indicating exponential growth and
Pharmaceutical Packaging Market Size, Share Growth Status, Emerging Technology, Key Players, Industry Challenges, and Forecast till 2032
Pharmaceutical Packaging Market Size, Share Growth Status, Emerging Technology, …
In the ever-evolving landscape of the pharmaceutical industry, packaging plays a pivotal role in ensuring the safety, efficacy, and integrity of medical products. The pharmaceutical packaging market is witnessing dynamic growth driven by technological advancements, stringent regulatory requirements, and increasing demand for personalized medicine and biologics. With a focus on patient safety, convenience, and sustainability, the market is undergoing transformative changes, fostering innovation and creativity among industry players. Pharmaceutical Packaging Market
US Color Cosmetics Market Report Presents an Overall Analysis, Development Trends, Driving Forces, Opportunities
US Color Cosmetics Market Report Presents an Overall Analysis, Development Trend …
Color cosmetics have long been an integral part of American culture, offering a wide range of products to enhance beauty and express individuality. The US color cosmetics market is a dynamic and vibrant landscape, driven by evolving consumer preferences, innovative product offerings, and changing beauty trends. In this article, we explore the key drivers, trends, restraints, and opportunities shaping the US color cosmetics market. The US Color Cosmetics Market was valued
US Takeout Containers Market Key Players, End User Demand and Analysis Growth Trends by 2032
US Takeout Containers Market Key Players, End User Demand and Analysis Growth Tr …
Takeout containers have become an integral part of the modern dining experience, offering convenience and portability for consumers on-the-go. In the United States, the takeout containers market has witnessed significant growth in recent years, driven by changing consumer lifestyles, the rise of food delivery services, and increasing environmental concerns. This article explores the key trends, drivers, restraints, and opportunities shaping the US takeout containers market. US Takeout Containers Market size was

All 5 Releases


More Releases for Depression

Increase in the prevalence of anxiety disorders and depression is bolstering the …
The research report "Global Anxiety Disorders and Depression Treatment Market: By Product Type (MAOIs (Monoamine Oxidase inhibitors), Atypical Antipsychotics, Benzodiazepines, Anticonvulsants, Beta-Blockers, SRIs (Selective Serotonin Reuptake Inhibitors), SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors), TeCAs (Tetracyclic Antidepressants), TCAs (Tricyclic Antidepressants), Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Others), and Geography- Global/Region/Country Forecast to 2028." The global anxiety disorders and depression treatment market size was valued at USD 8.2 Bn in the year
Depression Treatment Device Market: Information by Product Type (Light Therapies …
Depression is characterized by multiple mental health challenges that involve a lack of positivity, suicidal thoughts, insomnia, anxiety, loss of appetite, and sadness. Depression is caused by a combination of biological, genetic, environmental, and psychological factors. Globally, the prevalence of depression is increasing at an alarming rate. About 300 million people of all ages suffered from depression and the suicide rate rose to about 8,00,000 individuals in 2018. As per
Depression Cannot Hit A Moving Target
Cottonwood Heights, Utah, Mar 12, 2020 -- Depression can't hit a moving target. That was a phrase to live by for Chelsea Hansen. She was full of life and love, and she had big goals. But soon she was to discover that life doesn't turn out the way she planned. Behind the Fake Smile is a fictional book based on real-life experiences. It's the story of how Chelsea navigates a world
Depression Drugs Market: Increase in Cases of Depression to Boost Market Growth
Transparency Market Research (TMR) has published a new report titled, “Depression Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global depression drugs market was valued at US$ 6,500 Mn in 2017 and is anticipated to decline at a CAGR of 2% from 2018 to 2026. The report suggests that rise in incidence of major depression disorders is projected to drive
Depression Therapeutics Market Forecast till 2025
Antidepressants are used to treat a wide range of mental disorders, including depression, anxiety, and major depressive disorder. Certain neurotransmitters in the brain exist in chemical form such as dopamine and serotonin, which are responsible for maintaining emotional balance such as mood and behavior. Antidepressants cover a wide range of drug categories, including selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants
Depression Drug Market: Global Depression Drug Forecast Will Reach $16.8 billion …
Zion Market Research has published a new report titled “Depression Drug (Benzodiazepines, SNRIs, TCAs, TeCAs, Atypical Antipsychotics, Monoamine Oxidase inhibitors and Others) Market: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 – 2020” According to the report, the global depression drug market was valued at USD 14.51 billion in 2014 and is expected to generate revenue of USD 16.8 billion by end of 2020, growing at a CAGR of 2.50%